Replies to post #11355 on Revive Therapeutics Ltd (RVVTF)

[Bruinfan4ever]

It's not about competing, it's about having a drug that works. Then you become that Goliath. Some of these giant companies started in penny land too.

[ReikoBlack]

I'm more curious to see Eli's side effects/safety profile data on their drug from their most recent study.

This is from June 2018. This is Eli's rheumatoid arthritis drug, sold under the brand name Olumiant.

FDA approves Olumiant for treatment of rheumatoid arthritis

"Olumiant is accompanied by a boxed warning about the risk of serious infections, malignancies, and thrombosis. Patients taking Olumiant also have experienced tuberculosis and opportunistic viral, fungal, and bacterial infections. These infections have led to hospitalization or death."
https://www.mdedge.com/rheumatology/article/167126/rheumatoid-arthritis/fda-approves-olumiant-treatment-rheumatoid

that was my point

if Eli Lily has something comparable they can crush us. I agree with you it lends credibility to rvvtf but we won't be competing with that goliath.

best to you